Clover Health CEO Jamie Reynoso Sells 9,273 Shares

What Happened
Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments (CLOV), sold 9,273 shares on 2026-09-15 in an open-market/private sale. The filing reports a weighted average price of $4.78 per share for proceeds of approximately $44,325; individual sales occurred at prices ranging from $4.70 to $4.78. According to the filing, these sales were to satisfy tax-withholding obligations tied to the vesting of the final 6.25% tranche of RSUs granted on September 16, 2022 — not discretionary directional trades.

Key Details

• Transaction date: 2026-09-15 (Filed same day; no late filing indicated)
• Transaction type: Sale (S) — sell-to-cover for tax withholding (per footnote)
• Shares sold: 9,273; weighted average price: $4.78; price range: $4.70–$4.78
• Proceeds: ≈ $44,325
• Reason: Mandatory sell-to-cover to satisfy tax withholding on vested RSUs (final 6.25% tranche)
• Shares owned after transaction: Not disclosed in this Form 4
• Footnote offer: Reporting person will provide a breakdown of shares sold at each price upon request

Context
Sell-to-cover transactions are common when restricted stock units vest and employers require withholding; the filing explicitly states these sales were mandated by the company’s equity plan and do not represent discretionary selling by the insider. For retail investors, such tax-withholding sales typically offer limited insight into the insider’s view of the company’s stock direction.